Scientific Sessions
Scientific Sessions
  • Program
  • #AHA24
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
Resources
  • Program
  • #AHA24
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
Sep 30th, 2021

Main Events to explore cutting-edge science and more

Scientific Sessions features daily Main Events showcasing critical and current scientific findings and not-to-miss features.


Getty Images 1291052421

Each day of Scientific Sessions will kick off with Main Events of critical and current scientific findings. The sessions will be jam-packed with not-to-miss features. Here’s a sample of what you can expect during the Main Events:

All times are EST

Saturday, Nov. 13

9:30 a.m.
-      Managing Stable CAD in a Post-Ischemia World
-      Cardio-Oncology: From a Science Journey to a Patient Journey

11 a.m.
-       Novel Strategies to Promote Healthy Vascular Aging
-
       Cardiovascular Health After 10 Years: What Have We Learned, and What Is the Future? 
-       ACC/AHA Valvular Heart Disease Guidelines: What You Need to Know and What Comes Next

3 p.m.
-       Atrial Fibrillation in 2021: Prepare for New Directions

4:30 p.m.
-       Organ on Demand: 3D Printing for CVD
-       Structuring the Future: Planning and Imaging of Structural Heart Interventions

Sunday, Nov. 14
8 a.m.
-       Paul Dudley White International Lecture and Session
-       War on Pulmonary Embolism: Ending Complacency in the Face of Critical Clinical and Research Challenges

9:30 a.m.
-       Science Catalyst Keynote and Thomas Smith Memorial Lecture
-       Rapid Fire Results From AHA Research on COVID-19

3:30 p.m.
-       Where Should New Heart Failure Guidelines Change in 2021?
5 p.m.
-       Single-Cell Profiles in Cardiovascular Diseases

Monday, Nov. 15
8 a.m.
-       Digital Impact on Disparities in Cardiovascular Care: Can Big Tech Step up to the Challenge?
-       Singling Out Cardiac Fibrosis and Regeneration: Insights From Single Cell Biology
9:30 a.m.
-       Long-Term COVID-19: Cardiopulmonary Translational Science
11 a.m.
-       Confronting the Tide of Heart Failure in Diabetes: From Mechanisms to Management

Refer to the Online Program Planner for more details.

Interesting Stories
Lp(a) and Peripheral Artery Disease Toolkit
Sponsored by Kaneka Corporation
Lp(a) and Peripheral Artery Disease Toolkit
Screening for Kidney Disease to Reduce CVD Risk
Sponsored by Bayer
Screening for Kidney Disease to Reduce CVD Risk
CME Gameshow Style Sympo: Navigating New Paradigms in Thrombosis Management
Sponsored by Medscape
CME Gameshow Style Sympo: Navigating New Paradigms in Thrombosis Management
Unmet Needs in Hypertension Toolkit
Sponsored by Medtronic
Unmet Needs in Hypertension Toolkit
More Content
Getty Images 1180201381
Daily Coverage
Join the Scientific Sessions 2022 Scavenger Hunt
Aug 15th, 2022
Live Meeting Image
AHA21
Member Connect
Dec 13th, 2021
P104 Steven Botts Image
AHA21
Members Connect: ERG Governs Chromatin Accessibility in Aortic Endothelial Cells
Dec 13th, 2021
Pres Address Lloyd Jones2
AHA21
Watch: #AHA21 recap and look ahead
Nov 22nd, 2021
Getty Images 1301907602
AHA21
Mark your calendar for #AHA22
Nov 19th, 2021
Elaine Hylek, MD, MPH, and Bruno Caramelli, MD, PhD
AHA21
Trials’ results suggest advancements in treatment approaches for AF and insight on the cardiac effects of coffee consumption
Nov 19th, 2021
Lbs02 Group Blood Patel
AHA21
Update on local and global hypertension science
Nov 19th, 2021
Getty Images 1219980553 61849bc953192
AHA21
Read all about #AHA21 in your daily coverage
Nov 16th, 2021
(from left to right): Brahmajee K. Nallamothu, MD, MPH, FAHA, Rhoda Au, PhD, Seth Martin, MD, MHS, FAHA, and Andrea Beaton, MD, FAHA
AHA21
QCOR at Sessions: mHealth strategies could help treat CVD around the world
Nov 15th, 2021
(from left to right, top to bottom rows): Corey E. Ventetuolo, MD, MS, Magdi Yacoub, OM, FRS, Karen Joynt Maddox, MD, MPH, FAHA, Gregory Lewis, MD, Marco Guazzi, MD, PhD, FAHA, Ana Macumbi, MD, PhD, FESC, Mark T. Gladwin, MD, FAHA, and William Bain, MD
AHA21
The shifting profile of cardiopulmonary COVID-19 survivors
Nov 15th, 2021
(from left to right): Jonathan P. Piccini, MD, MHS, FAHA, and Steven A. Lubitz, MD, MPH, FAHA
AHA21
Late-Breaking Science: New information in cardiac disease
Nov 15th, 2021
(from left to right): Nasrien E. Ibrahim, MD, Stefan D. Anker, MD, PhD, and Clyde W. Yancy, MD, MSc, FAHA
AHA21
The latest science in heart failure
Nov 15th, 2021